Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

NRIX — Nurix Therapeutics, Inc.

UNDERVALUED (MOS +53.9%) · Quality 89/100

Value Score 30 days ago: 5.8 → today 71.4

NRIX - Nurix Therapeutics, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 16.33 USD
Intrinsic value: 35.42 USD
Margin of safety: +53.9%
Implied growth (reverse DCF): -6.4% (model assumes +5.6%)
Valuation: UNDERVALUED
Value Score: 71.4
Quality: 89/100
Moat score: 5 (erosion: none)
UNDERVALUED (MOS +53.9%) - Quality 89/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/NRIX
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

16.33

Intrinsic value

35.42

Margin of safety

+53.9%

Implied growth (reverse DCF)

-6.4%

model assumes +5.6%

Value Score

71.4

Quality

Psychology

38.9

Discovery

122.3

price/volume attention only

Moat score

erosion: none

Value Score: top 1% of Russell 3000 · Quality: top 2%

Open the interactive Deep Dive for NRIX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/NRIX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is NRIX undervalued?

As of 2026-11-11, NRIX trades at 16.33 against a computed intrinsic value of 35.42 (+53.9% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Nurix Therapeutics, Inc.'s Value Score?

Nurix Therapeutics, Inc.'s Value Score is 71.4 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.